Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Former Life Technologies and BD Biosciences Executive John L. “Kip” Miller Joins Solulink’s Board of Directors

Published: Wednesday, September 04, 2013
Last Updated: Wednesday, September 04, 2013
Bookmark and Share
Mr. Miller brings a successful track record of life science leadership and in-depth knowledge of the life science and flow cytometry markets to Solulink’s Board.

Solulink, Inc. announced John L. “Kip” Miller has joined the company’s Board of Directors. The addition of Mr. Miller to the Solulink board will be instrumental as the company commences commercialization of its HybriLink™ technology.

The HybriLink technology solves the ‘missing color’ problem: the inability to find the needed antibody labeled with the right fluorophore (color). Often, the desired combination is not commercially available. By providing a simple way to mix and match any fluorophore with any antibody on demand, just‐in‐time at the point‐of‐use, HybriLink dramatically streamlines the development and expansion of multicolor flow panels for flow cytometry research labs. Solulink believes that HybriLink’s ability to offer all antibodies in all fluorophores – including the next generation of emerging fluorophores – resolves a fundamental challenge in flow cytometry and will expand the overall flow cytometry reagents market size.

Mr. Miller brings a solid track record of life science leadership with a strong background in commercial operations, and extensive experience in the life science research and diagnostic markets. Most recently, Mr. Miller served as President of Genetic Systems at Life Technologies. From 2008 to 2011, he served as Senior Vice President of Biodiscovery at Invitrogen Corporation, which merged with Applied Biosystems in 2008 to form Life Technologies. Prior to joining Invitrogen Corporation, Mr. Miller served in various capacities for BD including VP GM of BD Biosciences Research Cell Analysis Business, VP GM of BD Pharmingen and VP Sales and Service the Americas’. Mr. Miller holds a B.S. in Packaging Engineering from Michigan State University.

Currently, Mr. Miller is a co‐founder and member of the Board of Directors at Tonbo Biosciences, and a member of the Board of Directors at Firefly BioWorks.

“We are delighted to welcome Kip to the Solulink board, and excited by the prospect of working with this dynamic leader to advance Solulink’s new HybriLink technology,” said Walt Young, Solulink’s Chairman of the Board. “Kip’s perspective and expertise will be invaluable as Solulink pursues its new HybriLink products for flow cytometry and implements their commercialization strategy.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos